Cell Reports Methods

Cell Reports Methods is a gold open access methods journal from Cell Press, first published in May 2021, devoted to robust and reproducible techniques across the life and physical sciences, with a 2025 Journal Impact Factor of 5.8.《细胞报告方法》（Cell Reports Methods）是（Cell Press）旗下的金色开放获取方法学期刊，2021 年 5 月首期出版，专注于生命与物理科学中稳健且可重复的技术，2025 年期刊影响因子为 5.8。

Scope

• The test for acceptance is a method that is robust, reproducible and likely to accelerate work in other laboratories, not a biological discovery as such.录用标准是方法本身稳健、可重复并能加速其他实验室的工作，而不是生物学发现本身。
• Sequencing and imaging technologies, including single-molecule approaches, form the core of the journal's coverage.测序与成像技术，包含单分子方法，构成本刊覆盖范围的核心。
• Genome editing, synthetic biology and biotechnology are in scope, and new tools or sets of reagents are considered when they are of clear utility to the community.基因组编辑、合成生物学与生物技术属收稿范围，对社区有明显用途的新工具或试剂组合亦在考虑之列。
• Computational methods, software and analysis pipelines are published alongside bench techniques, and code must be available to reviewers.计算方法、软件与分析流程与实验技术并列发表，代码须向审稿人开放。
• Proteomics, single-cell analysis, high-content screening and organoid or animal models appear regularly.蛋白质组学、单细胞分析、高内涵筛选以及类器官或动物模型经常出现。
• Article types include Reports for short single-point stories, full Articles, Resources, Perspectives, Commentaries, Protocol Reviews and Voices.文章类型包括面向单一要点的短篇报告、完整论文、资源类论文、观点、评论、实验方案综述以及访谈。
• Descriptive applications of an existing method without a demonstrable advance fall outside the journal's remit.对既有方法的描述性应用若无可证实的推进，则不属于本刊范围。

History

• The title launched in May 2021 as the first open access methods journal in the Cell Reports portfolio, and the first issue carried six manuscripts.本刊于 2021 年 5 月创刊，是（Cell Reports）系列中第一本开放获取方法学期刊，首期刊载 6 篇稿件。
• At its first anniversary the journal had published 127 research articles, reviews and other content, and it used the occasion to add the Resource format.创刊一周年时，本刊已发表 127 篇研究论文、综述及其他内容，并借此增设了资源类论文格式。
• Authors may co-publish a step-by-step protocol in STAR Protocols, and the protocol fee is waived when it is considered alongside a paper in this journal.作者可将分步实验方案在（STAR Protocols）联合发表，与该刊论文同步送审时免除方案处理费。
• Publication is monthly, and the journal applies the STAR Methods structure so that reporting is transparent and repeatable.期刊按月出版，并采用（STAR Methods）结构，使方法报告透明且可复现。
• The 2025 Journal Impact Factor is 5.8, against 4.5 in 2024.2025 年期刊影响因子为 5.8，2024 年为 4.5。
• In the 2025 Journal Citation Reports it is first quartile in biochemical research methods, ranked 9th of 85, and second quartile in cell biology.在 2025 年期刊引证报告中，本刊在生化研究方法类 85 种期刊中位列第 9，属第一四分位，在细胞生物学类属第二四分位。

Editors

• Ruth Zearfoss is editor-in-chief, based at Cell Press in Boston, Massachusetts. She joined from Cell Reports, where she was deputy editor for six years.Ruth Zearfoss 任主编，常驻马萨诸塞州波士顿的（Cell Press）；她此前在（Cell Reports）任副编辑六年。
• Emily Marcinkevicius and Kusumika Mukherjee are senior scientific editors in Cambridge, Massachusetts, and handle manuscripts through the review process.Emily Marcinkevicius 与 Kusumika Mukherjee 是常驻马萨诸塞州剑桥的高级科学编辑，负责稿件评审全流程。
• Alex Munro-Clark in London and Leila Shokri in Cambridge serve as consulting editors, extending editorial coverage across time zones.伦敦的 Alex Munro-Clark 与剑桥的 Leila Shokri 担任顾问编辑，使编辑覆盖跨越时区。
• Editing is professional and in-house, supported by an active editorial board of researchers, so decisions rest with the editors rather than with guest academic editors.编辑工作由社内专业编辑承担，并有活跃的研究者编委会支持，决定权在编辑而非客座学术编辑。
• The median time to first decision is seven days, and the median from acceptance to online publication is about 26 days.初审中位时间为 7 天，从录用到在线出版的中位时间约为 26 天。
• The journal takes part in Cell Press Multi-Journal Submission, so one manuscript can be considered by several titles at once, and pre-submission enquiries go to the journal inbox.本刊参与（Cell Press）多刊联合投稿机制，一篇稿件可同时被数种期刊考虑，投稿前咨询可直接发至编辑部邮箱。